Page 2 - Metropolis Healthcare

Metropolis Healthcare jumps 17% on strong long-term growth prospects

The brokerage expects the healthcare company to benefit from its aggressive B2C expansion, where it has expanded its network touch points by ~6.6X over the past 3.5 years

Coronavirus pandemic: Stocks of diagnostic firms could prove safe bets

Though details of Covid19-testing reimbursement are crucial to ascertain the earnings impact, other growth levers remain intact

Thyrocare Tech, Dr Lal Path Labs surge as pvt labs to conduct Covid-19 test

That apart, national laboratories have also been allowed to carry out clinical testing of Covid-19, as the number of cases went past 400 in India.

Metropolis, Thyrocare say they will start tests for coronavirus from today

They would start collecting samples for testing from today. For starters, this would happen in Mumbai

From Sanjay Sethi to Ameera Shah, meet new entrants in BS1000 club

The latest members of the BS1000 club have bet on capital expenditure, acquisitions and partnerships for growth

Metropolis Healthcare hits record high, surges 41% in 2 months

The stock has zoomed 125 per cent against its issue price of Rs 880 per share

Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

Since, 2002, Metropolis has used its brand strength to establish large networks through acquisitions in Chennai, Rajkot, Surat, Bangalore, Pune as well as outside India

Metropolis Healthcare Q2 revenue up 15% to Rs 223 crore, PAT rises 43.7%

The profit after tax works out to Rs 43 crore in Q2 FY20, up 43.7% from Rs 30 crore in Q2 FY19

Serial entrepreneur G S K Velu to ramp up diagnostics biz in west and south

Move follows expiry of restrictive clauses inserted at the time he sold his stake in Metropolis Healthcare to Carlyle Group

Metropolis Healthcare shares gain 9% over issue price on debut

On a price-to-earnings (P/E) valuation basis, analysts said Metropolis is cheaper than Dr Lal Pathlabs

Metropolis Healthcare open to acquisitions; IPO to hit Street on Wednesday

Sushil Shah, chairman of Metropolis Healthcare, said if a good acquisition opportunity came up, they were open to evaluate it

Diagnostics firm Metropolis Healthcare files IPO draft papers with Sebi

Shares of the company are proposed to be listed on BSE and NSE

Metropolis' Ameera Shah resists listing

Rivals Dr Lal's and Thyrocare command valuations over 50 times earnings

Metropolis Healthcare eyes Asia markets for growth

The firm, which had exited South Africa in August, now is quite bullish about Africa as a market